January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 27, 2026
The Europe pharmaceutical CDMO market size is calculated at $37.98 bn in 2025 is to hit $ 74.99 bn by 2035. In 2024, Germany led the European pharmaceutical CDMO market, with France expected to experience the fastest growth. The API segment dominated by product, while the commercial segment led by workflow. Oncology was the top application, and lar...
January 27, 2026
According to our projections, the contamination detection in pharma products sector is expected to grow from USD 2.93 billion in 2025 to USD 6.76 billion by 2035, reflecting a CAGR of 8.7%. Market insights predict the contamination detection in pharma products market is growing as it is a significant technology in the medical care sector to ensure ...
January 27, 2026
Based on market forecasts, the GCC compounding pharmacy market, projected at USD 17.91 million in 2025, is expected to reach USD 43.46 million by 2035, growing at a CAGR of 9.27% over the forecast period.The growing demand for personalized medicines and technological advancements is the major growth factor of the market. Saudi Arabia led the market...
January 22, 2026
According to our projections, the global lung cancer trial market, valued at USD 4.34 billion in 2025, is anticipated to reach USD 9.76 billion by 2035, growing at a CAGR of 8.45% over the next decade. The lung cancer trial market is growing due to it helps inform the lung cancer patient community related to novel medications and advances in types ...
January 21, 2026
Based on our market research, the global medical device CMO and CDMO industry will increase from USD 48.39 billion in 2025 to USD 110.82 billion by 2035, achieving a CAGR of 8.64%....
January 21, 2026
Based on our estimations, the U.S. Cell and Gene Therapy CRO market was valued at USD 2.33 billion in 2025 and is projected to grow from USD 2.56 billion in 2026 to USD 6.02 billion by 2035, registering a CAGR of 9.95% during 2026–2035....
January 19, 2026
Based on market forecasts, the U.S. digital health market, projected at USD 88.38 billion in 2025, is expected to reach USD 266.5 billion by 2035, growing at a CAGR of 11.67% over the forecast period. The market is growing due to the increasing adoption of telemedicine, wearable devices, and health apps for remote monitoring and personalized care. ...
January 16, 2026
Market insights predict the global third-party medical institutions industry will increase from USD 254.88 billion in 2025 to USD 528.27 billion by 2035, achieving a CAGR of 7.56%. The global third-party medical institutions market is expanding as healthcare demand rises, especially with North America leading in 2023. These institutions provide ess...
January 16, 2026
Our projections indicate, the U.S. Cell and Gene Therapy CDMO market is experiencing exponential growth driven by expanding clinical pipelines and increasing outsourcing of complex biologics manufacturing. With revenues projected to rise from USD 4.02 billion in 2026 to USD 37.5 billion by 2035, the market is set to grow at a 28.15% CAGR during the...
January 15, 2026
The diabetic retinopathy industry is projected to rise from USD 10.14 billion in 2025 to USD 18.97 billion by 2035, reflecting a CAGR of 6.47% over the next decade. In 2024, North America led the diabetic retinopathy market, while Asia-Pacific is set for strong growth. Non-proliferative diabetic retinopathy held the largest share, but proliferative...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
